The Role of the UK in the European Cannabis Market

6 May 2019 | 16:30 - 17:00

Because of the importance of the UK in the European market, the cannabis industry received the news of medical cannabis reform last November with extreme optimism. But currently, the National Health Service website states that “very few people in England are likely to get a prescription for medical cannabis.” And they mean it. Only a handful of patients have accessed medical cannabis in the UK—and only at a prohibitive cost.

You’ll get insights on:

  • The implications of Brexit on the future of the UK’s cannabis market.
  • How imports work and issues of access for cannabis patients.
  • The role of “evidence” and how CBD fits into the equation.